SYMELab
Trang chủThư Viện HươngMyrtle (lemon), Lemon-scented myrtle, Lemon ironwood, Sweet verbena tree
The Perfumer's Grimoire

Tinh dầu sim chanh

Myrtle (lemon), Lemon-scented myrtle, Lemon ironwood, Sweet verbena tree

Backhousia citriodora F. Muell.

TopCam chanh

Hương chanh đậm đặc, citral cực đại chiếm ưu thế, hương tươi sạch, chanh ngọt, geranial chiếm ưu thế chính, neral phụ, mùi kẹo chanh, mùi nước chanh, hương vỏ chanh đậm đặc, đặc trưng Backhousia citriodora, đặc hữu rừng nhiệt đới Queensland Úc, dẫn đầu lớp chanh

Chân dung Hương

Sáu trục định hình cá tính khứu giác của tinh chất này.

Mang tinh chất này vào sáng tạo của bạn

Đưa tinh chất vào bàn pha chế thủ công hoặc để AI Perfumer dệt nên một công thức hương đồng hành cùng nó.

Tóm Tắt Khoa Học

Từ Thư Viện Kinh Điển

Lemon myrtle / lemon-scented myrtle essential oil (Backhousia citriodora F. Muell., Myrtaceae — Australian-Queensland-rainforest endemic; "lemon ironwood" / "sweet verbena tree" Australian colloquial) is a citral-EXTREME-DOMINANT leaf-distilled EO with CITRAL-HARD-CAP HAZARD signature (T&Y EXPLICIT max dermal 0.7% + max oral pregnancy 46 mg/d via 90% citral content × Ch.14 citral 0.6% dermal + 0.6 mg/kg oral; CRITICAL CYP2B6 inhibition drug-interaction rail T&Y EXPLICIT Table 4.11B — bupropion / efavirenz / cyclophosphamide / ifosfamide / ketamine / methadone / nevirapine; CRITICAL teratogenicity rail T&Y EXPLICIT via citral retinoic acid synthesis inhibition; CRITICAL skin-sensitization rail T&Y EXPLICIT Bonefeld 2010 + IFRA 2009 0.6% body-oils dermal cap). B216 Ch.13 p.713 cites Southwell et al 2000 chemistry: Geranial 46.1–60.7% (major-dominant) + Neral 32.0–40.9% (secondary, geometric isomer of geranial — combined CITRAL ≈ 78–100%) + Isogeranial 1.0–4.2% + Isoneral 0.6–2.7% + 6-Methyl-5-hepten-2-one 0.1–2.5% + Linalool 0.3–1.0%. Hazard signature B216 EXPLICIT verbatim: "Hazards: Drug interaction; teratogenicity; skin sensitization." Cautions all routes B216 EXPLICIT: "Drugs metabolized by CYP2B6 (Appendix B)." Cautions oral B216 EXPLICIT: "Diabetes medication, pregnancy." Cautions dermal B216 EXPLICIT: "Hypersensitive, diseased or damaged skin, children under 2 years of age." Maximum daily oral dose in pregnancy: 46 mg (T&Y EXPLICIT). Maximum dermal use level: 0.7% (T&Y EXPLICIT — derived from 90% citral × Ch.14 citral 0.6%). IFRA 2009 EXPLICIT maximum dermal use level for citral 0.6% for body oils + lotions to avoid skin sensitization. Adverse skin reactions B216 EXPLICIT: Veien 2004 0/217 dermatitis patients reactive at 2% (clinical-clean rail at 2%); Burke 2004 31 children mean age 4.6yr 10% in olive oil 21 days no significant adverse effects (clinical pediatric clean rail at 10%); Hayes & Markovic 2003 100µL undiluted 12hr only neral + geranial detected in skin; histopathological skin changes suggested mild skin irritation + corrosion; calculated 70 kg adult absorbed 0.02 mg/kg + 10 kg child 0.14 mg/kg — both BELOW NOAEL 0.5 mg/L. Citral sensitization rail T&Y EXPLICIT: patch testing >0.5% can induce sensitization, allegedly inhibited by co-presence of (+)-limonene OR α-pinene (B216 Ch.14). Reproductive toxicity B216 EXPLICIT verbatim: "Citral is dose-dependently teratogenic because it inhibits retinoic acid synthesis, and this can affect fetal development (see Citral profile, Chapter 14)." Cardiovascular effects B216 EXPLICIT: Modak & Mukhopadhaya 2011 citral 10/15/20 mg/kg/day 28 days dose-dependently lowered plasma insulin + increased glucose tolerance in obese rats → antidiabetic-medication interaction rail T&Y Table 4.10B. Carcinogenic-dual-class rail B216 EXPLICIT: Hayes & Markovic 2002 strongly cytotoxic vs HepG2 (liver) + F1-73 (epithelial) + skin fibroblasts; NOAEL calculated 0.5 mg/L at 24hr; citral anticarcinogenic-class also documented per Ch.14 → cytotoxic + anticarcinogenic dual-class rail. Drug interactions B216 EXPLICIT: "Antidiabetic medication... See Table 4.10B. Since citral inhibits CYP2B6 (Table 4.11B), there is a theoretical risk of interaction between lemon myrtle oil and drugs metabolized by this enzyme (Appendix B)." Quality rail B216 EXPLICIT verbatim: "May be adulterated with synthetic citral." Comments + commercial-emergence rail B216 EXPLICIT verbatim: "If 10 mL of lemon myrtle oil was to come into contact with the skin accidentally, concentrations of neral and geranial in the body could be as high as 2.0 mg/kg in an adult and 14.0 mg/kg in a child. This would exceed the NOAEL (Hayes & Markovic 2003). Lemon myrtle oil became commercially available in 1997." → CRITICAL accidental-spill-emergency rail = 10 mL undiluted skin contact exceeds NOAEL especially in child — first-aid-protocol rail mandatory. Citral-EXTREME-DOMINANT class-rail (78–100%): combined geranial + neral + isogeranial + isoneral citral-isomer-cluster — class-shared with [[lemongrass]] EO042 (West Indian) ~77% citral + East Indian ~83% citral + verbena lemon ~26.7% citral + [[may-chang]] EO057 (Litsea cubeba) 73.8% citral + [[lemon-balm]] EO759 23c citral 17.6% — HIGHEST citral content EO in commercial trade per B216 EXPLICIT "< 90.0% sources >1.0%"; class-leader citral-DOMINANT-EO peer cluster. Lemon-scented-EO-cluster rail: lemon myrtle (this oil — citral 78–100%) class-shared with [[lemon-balm]] EO759 23c Eucalyptus staigeriana citral 17.6% (lemon-scented Australian Myrtaceae cousin) + lemongrass East/West Indian + may-chang/litsea + lemon-tea-tree Leptospermum petersonii + verbena lemon — Myrtaceae-genus-Backhousia + Eucalyptus + Leptospermum cross-genus citral-DOMINANT cluster all from Australia + Asia. Australian Myrtaceae endemic-class rail: B. citriodora Queensland-rainforest endemic; class-shared with [[fragonia]] EO727 19a + manuka Leptospermum scoparium + kanuka Kunzea ericoides EO749 22b + many Australian Myrtaceae endemic genera. Myrtaceae-CITRAL-CT class-rail: B. citriodora (this oil — citral-CT) vs Backhousia anisata myrtle-aniseed (estragole 4.4%-CT) vs Eucalyptus staigeriana lemon-balm EO759 (citral 17.6% chemotype) — same-family Myrtaceae but radically different chemistry + safety profile. Continues Mini-Batch 26b heterogeneity-progression (Myricaceae-clean myrtle-bog EO775 → Myrtaceae-citral-HARD-CAP myrtle-lemon [this oil] → Cyperaceae-clean nagarmotha EO777).

🌿
Thận trọngNốt TopLemon-citrus-EXTREME

Myrtle (lemon), Lemon-scented myrtle, Lemon ironwood, Sweet verbena tree

Tinh dầu sim chanh (lemon-scented myrtle Úc)

Backhousia citriodora F. Muell.

Tinh dầu sim chanh (lemon-scented myrtle Úc) — Lemon-citrus-EXTREME

⚠️Tinh dầu này cần thận trọng khi sử dụng. Đọc kỹ hướng dẫn an toàn.

Tổng Quan

Danh pháp khoa học
Backhousia citriodora F. Muell.
Họ thực vật
Myrtaceae
Bộ phận dùng
Leaves
Phương pháp chiết xuất
steam_distillation
Màu sắc
Phân loại nốt hương
Nốt Top
Hương thơm
Chemotype / Cultivar

Các quốc gia sản xuất chính

Australia

Tình trạng tại Việt Nam

Xem chi tiết

Phân loại nốt
Top
Cường độ
4/5
Độ bền trên da
2–4 giờ
Họ hương
Lemon-citrus-EXTREME
Hương đầu (Opening)(0–15 phút)

Intense-lemon, citral-EXTREME-DOMINANT, fresh-clean, sweet-lemon, geranial-major, neral-secondary, lemon-candy, lemonade-like, lemon-zest-concentrated, Backhousia citriodora signature, Australian-Queensland-rainforest-endemic, lemon-class-leader

Hương giữa (Heart)(15–60 phút)

Hương chanh đậm đặc, citral cực đại chiếm ưu thế, hương tươi sạch, chanh ngọt, geranial chiếm ưu thế chính, neral phụ, mùi kẹo chanh, mùi nước chanh, hương vỏ chanh đậm đặc, đặc trưng Backhousia citriodora, đặc hữu rừng nhiệt đới Queensland Úc, dẫn đầu lớp chanh

Hương nền (Drydown)(1–4 giờ)

2–4 giờ

Cường độ hương
4/5
Da khô
1/5

Da dầu/mụn
2/5

Da lão hóa
2/5

Da thường
3/5

Da nhạy cảm
1/5

Da hỗn hợp
2/5

Nhập khẩuImported

Tên gọi tại Việt Nam

Tinh dầu sim chanh (lemon-scented myrtle Úc)

Pha Chế & Hòa Hợp

antiviral — molluscum contagiosum

Citral fraction (geranial + neral, 78–100% combined) disrupts viral membrane integrity; a controlled pediatric clinical trial demonstrated significant molluscum contagiosum lesion clearance over 21 days of topical application.

Ref: Burke et al 2004

antimicrobial — broad-spectrum

Geranial and neral (dominant aldehydes, 78–100% total) exert bactericidal and bacteriostatic activity via disruption of microbial cell membrane integrity and inhibition of essential enzyme systems.

Ref: B216 Ch.14 citral profile (Tisserand & Young 2014)

antifungal

Citral aldehydes impair fungal membrane function through interference with ergosterol-dependent biosynthetic pathways; class mechanism shared across citral-dominant Myrtaceae and Poaceae essential oils.

Ref: class-extrapolation from citral-dominant EO class per B216 Ch.14 citral profile

antidiabetic — adjunctive (preclinical)

Citral at 10–20 mg/kg/day modulated fasting blood glucose in a 28-day rat model, suggesting possible insulin-sensitising or metabolic pathway involvement; no human clinical evidence established.

Ref: Modak & Mukhopadhaya 2011; B216 Table 4.10B

insect-repellent

High citral content (78–100%) provides olfactory deterrence against mosquitoes and other arthropods via receptor-mediated aversion; class mechanism shared with other citral-dominant oils such as lemongrass.

Ref: class-extrapolation from high-citral EO class per Tisserand & Young 2014, Ch.13

anticarcinogenic — in-vitro signal only

Citral induces glutathione S-transferase activity and displays in-vitro cytotoxicity against cancer cell lines; strictly a research-class signal with no in-vivo or clinical evidence supporting therapeutic use.

Ref: B216 Ch.14 citral profile (anticarcinogenic-class citation)

AI-summary

The strongest controlled evidence is Burke et al 2004 (31 children, mean age 4.6yr): a controlled trial of 10% lemon myrtle oil in olive oil applied topically over 21 days for molluscum contagiosum, with significant lesion clearance. Critically, the 10% concentration exceeds the TY adult safe maximum (0.7%) by ~14-fold, and the study population (children) is now a contraindicated group per Tisserand & Young 2014. Veien et al 2004 showed 0/217 reactors at 2% patch testing, providing partial reassurance of sensitisation risk profile. Hayes & Markovic 2002 established a cytotoxicity NOAEL of 0.5 mg/L in HepG2 and skin fibroblast cell lines; Hayes & Markovic 2003 demonstrated geranial and neral penetration at below-NOAEL levels following 100µL undiluted 12hr dermal exposure in adult and child models, suggesting manageable systemic absorption at safe dilutions.

Narrative

Tâm trạng: Uplifting, Stimulating

clarityinvigorationoptimismalertnessfocusrenewal

Chakra

solar

Ngũ hành

moc

Phương phápLiều lượngGhi chú
Diffusion2-3 drops per 100ml water in ultrasonic diffuserPhương pháp được ưu tiên — tránh tiếp xúc da và rủi ro nhạy cảm. Khuếch tán 30-60 phút/lần. Không dùng quanh trẻ nhỏ hoặc phụ nữ mang thai. Do not use steam diffusers with this oil.
Topical massage0.5–0.7% in carrier oil (max 4-5 drops per 30ml carrier)CONTRAINDICATED: pregnancy + children. Do NOT exceed 0.7% adult cap (TY 2014). Avoid on damaged or sensitised skin. Patch test 24hr before use. Use fractionated coconut or jojoba.
Skincare formulation0.5% max in leave-on products; 0.6% max in rinse-off (IFRA 2009)IFRA 2009 hard cap 0.6% body oils/lotions. CONTRAINDICATED: children + pregnancy. Minimum concentration only. Verify GC/MS — synthetic citral adulteration common (TY quality flag).
Steam inhalation1 drop in bowl of hot water; inhale 5-10 minutes with towel tentAvoids dermal sensitisation risk. For antimicrobial aromatic use in adults only. Caution in asthma — high citral may irritate airways if overused. AVOID in pregnancy and around children.
Room spray3-5 drops per 50ml distilled water with dispersantEffective air-freshening and surface-antimicrobial application. Shake before use — citral is not water-soluble. Ensure adequate ventilation. Suitable where skin contact is not intended.

Dầu nền phù hợp

Fractionated coconut oilOdourless and oxidatively stable; allows the sharp lemon-citral scent to remain unmasked while providing a non-comedogenic, lightweight base ideal for very dilute (0.5–0.7%) topical formulations.
Jojoba oilWax-ester structure gives exceptional shelf-stability and low sensitisation potential — critical contrast to citral's own sensitisation risk. Non-comedogenic for most adult skin types.
Sweet almond oilLight, emollient texture with good dermal penetration kinetics suited to very dilute formulations; aligns with Hayes & Markovic 2003 skin-penetration safety data for geranial and neral.
Rosehip seed oilHigh linoleic acid content supports mature skin applications where barrier function may be compromised; pairs with lemon myrtle's antimicrobial positioning at strict low concentrations.

Kết hợp tốt với

FloralGreenHerbaceousWoodySpicy

Blend kinh điển

[B216] Ch.13 p.713 Myrtle (lemon) profile (primary source)
[Southwell et al 2000] Backhousia citriodora essential oil chemistry profile (cited in B216 Ch.13 p.713)
[Veien et al 2004] Danish dermatitis study 0/217 reactive at 2% lemon myrtle oil
[Burke et al 2004] 31 children mean age 4.6yr 10% lemon myrtle in olive oil 21 days clinical molluscum contagiosum trial
[Hayes & Markovic 2002] Cytotoxicity HepG2 + F1-73 + skin fibroblasts NOAEL 0.5 mg/L
[Hayes & Markovic 2003] Skin penetration kinetics 100µL undiluted 12hr neral + geranial only detected, 0.02 mg/kg adult / 0.14 mg/kg child below NOAEL
[Modak & Mukhopadhaya 2011] Citral 10/15/20 mg/kg/day 28 days antidiabetic effect rat model
[B216 Citral profile Chapter 14] CYP2B6 inhibition + teratogenicity + skin-sensitization 0.5% + anticarcinogenic-class
[B216 Geranial + Neral profiles Chapter 14] citral isomer profiles
[IFRA 2009] citral 0.6% body oils + lotions skin-sensitization cap
[B216 Table 4.10B] antidiabetic medication drug-interaction reference
[B216 Table 4.11B] CYP2B6 drug-interaction reference

An Toàn

Giới hạn da tối đa

Xem chi tiết

Giới hạn IFRA

Xem chi tiết

Thai kỳ & Cho con bú

Tam cá nguyệt 1Unknown
Tam cá nguyệt 2Unknown
Tam cá nguyệt 3Unknown

Giới hạn độ tuổi

Xem chi tiết

Bảo quản

Bảo quản nơi tối, mát

Thông tin chỉ mang tính tham khảo, không thay thế tư vấn y tế chuyên nghiệp. SYMELab v2.0

Bí quyết Phối trộn

Mở khoá Premium để xem những cặp đôi cổ điển và nguyên liệu có ái lực hương với tinh chất này.

Nâng cấp Premium để mở khoá

Thông số Kỹ thuật & An toàn

Mở khoá Premium để xem giới hạn pha loãng, chống chỉ định, tương tác thuốc và tiêu chuẩn chất lượng.

Nâng cấp Premium để mở khoá

Đọc Thêm Chuyên Sâu

Nội dung biên dịch từ tài liệu gốc — mở rộng mỗi mục để xem chi tiết.

Hồ Sơ Hoá Học Chi Tiết
§3 Chemical Profile — chemotype, constituent ranges, adulteration

Per Southwell et al 2000 cited in B216 Ch.13 p.713:

Constituent%Role
Geranial46.1–60.7%Major-dominant — acyclic monoterpene aldehyde (E-isomer of citral, C10H16O); intense lemon-citrus character; T&Y Ch.14 citral profile cap 0.6% dermal + 0.6 mg/kg oral; CYP2B6 inhibitor; teratogenicity via retinoic acid synthesis inhibition; skin-sensitization >0.5% patch test; class-shared with all citral-rich EOs
Neral32.0–40.9%Secondary — acyclic monoterpene aldehyde (Z-isomer of citral, C10H16O); intense lemon-citrus character; geometric isomer of geranial; combined CITRAL = geranial + neral 78–100%; same hazard profile as geranial; class-shared all citral-rich EOs
Isogeranial1.0–4.2%Acyclic monoterpene aldehyde minor isomer of geranial; class-marker
Isoneral0.6–2.7%Acyclic monoterpene aldehyde minor isomer of neral; class-marker
6-Methyl-5-hepten-2-one0.1–2.5%Acyclic monoterpenoid ketone; floral-sweet-undertone trace
Linalool0.3–1.0%Acyclic monoterpenoid alcohol; minor — does NOT trigger latent-oxidation-class threshold (linalool 30%+ rail)

CITRAL combined (geranial + neral) ≈ 78–100% — class-extreme-dominance citral profile; T&Y EXPLICIT verbatim hard cap derivation 90% citral × Ch.14 citral 0.6% dermal = 0.7% × 0.78 / 0.90 = ~0.7% rounded; oral pregnancy 0.6 mg/kg × 70kg / 0.90 = ~46 mg/d.

Citral-isomer-cluster combined (geranial + neral + isogeranial + isoneral) ≈ 80–110% — citral + isomers near-pure profile; chemotaxonomic-class anchor for B. citriodora species authentication.

No-thujone, no-camphor, no-pulegone, no-methyleugenol, no-estragole, no-furanocoumarin, no-organosulfur class concerns per Southwell 2000 chemistry profile silence on these 7 hazard-class constituents — pure citral-class profile.

Citral teratogenicity-class T&Y EXPLICIT verbatim Ch.14: Citral inhibits retinoic acid synthesis dose-dependently affecting fetal development — class-rail with all citral-rich EOs (lemongrass East/West Indian + may-chang + verbena-lemon + lemon-balm EO759 + lemon-tea-tree).

Citral CYP2B6 inhibition T&Y Table 4.11B EXPLICIT: drug interaction with bupropion + efavirenz + cyclophosphamide + ifosfamide + ketamine + methadone + nevirapine — class-rail.

Citral skin-sensitization-class T&Y EXPLICIT Ch.14: patch testing >0.5% can induce sensitization; allegedly inhibited by co-presence of (+)-limonene OR α-pinene (lemon myrtle has minimal limonene + no α-pinene per Southwell 2000 — sensitization risk NOT mitigated).

Công Dụng Trị Liệu Chi Tiết
§10 Therapeutic Uses — skin, emotional, physical, respiratory

Per B216 + Australian-Aboriginal traditional + modern aromatherapy:

  • Antimicrobial / antifungal (citral-class strong activity vs broad-spectrum bacteria + fungi + Candida; in-vitro extensive evidence; class-shared with lemongrass + may-chang)
  • Anti-inflammatory (citral-class documented in-vitro)
  • Insect-repellent / mosquito-deterrent (citral-class; class-shared with citronella + lemongrass)
  • Anticarcinogenic-class research (B216 EXPLICIT documented in-vitro Hayes & Markovic 2002 strongly cytotoxic + Ch.14 citral anticarcinogenic-class — clinical translation NOT established; research-class anchor only)
  • Food + beverage flavoring (modern Australian niche industry; lemon-myrtle-leaf dried + tea + culinary spice)
  • Australian-Aboriginal traditional folk-medicine (Queensland indigenous bush-tucker leaf-flavoring + medicinal poultice + decoction — PLANT use, NOT concentrated EO; cultural-respect rail mandatory)
  • Skin-soothing CONTRAINDICATED at full strength — citral 0.7% hard cap means MOST skincare topical applications should use HEAVILY diluted preparations only; Burke 2004 children-clinical-trial 10% in olive oil for 21 days no significant adverse effects but B216 EXPLICIT "children under 2 years of age" dermal caution + "hypersensitive, diseased or damaged skin" caution + sensitization >0.5% patch test risk
  • Vietnamese aromatherapy context: Tinh dầu sim chanh (Backhousia citriodora F. Muell. — chi Backhousia họ Myrtaceae đặc hữu rừng nhiệt đới Queensland Úc, không phải sim thường Myrtus communis hoặc bất kỳ loài nào trong chi Myrica) là tinh dầu citral cực mạnh chiếm ưu thế tuyệt đối 78–100% combined (geranial 46.1–60.7% + neral 32.0–40.9%) chiết xuất từ lá. Hồ sơ an toàn: NGUY HẠI ĐA CẤP B216 EXPLICIT — tương tác thuốc (CYP2B6 + thuốc tiểu đường) + độc thai + nhạy cảm da. Mức độ pha loãng tối đa T&Y CHẶN CỨNG 0.7% (rất thấp vì hàm lượng citral cực cao); thai kỳ TRÁNH dùng ngoài da, đường uống tối đa 46 mg/ngày; trẻ dưới 2 tuổi TRÁNH dùng ngoài da B216 EXPLICIT; da nhạy cảm/tổn thương TRÁNH B216 EXPLICIT. CRITICAL CYP2B6 thuốc tương tác T&Y Bảng 4.11B EXPLICIT: bupropion (chống trầm cảm) + efavirenz (HIV) + cyclophosphamide (hóa trị) + ifosfamide (hóa trị) + ketamine (gây mê) + methadone (cai nghiện) + nevirapine (HIV). CRITICAL độc thai citral T&Y EXPLICIT thông qua ức chế tổng hợp acid retinoic — ảnh hưởng phát triển bào thai. CRITICAL nhạy cảm da T&Y EXPLICIT patch test >0.5% có thể gây nhạy cảm; được cho là giảm bởi co-presence của (+)-limonene HOẶC α-pinene (cả hai gần như không có trong tinh dầu này). Quality: B216 cảnh báo "có thể bị làm giả với citral tổng hợp". Khẩn cấp: B216 EXPLICIT 10 mL contact da vô tình → vượt ngưỡng NOAEL ở trẻ em 14.0 mg/kg / người lớn 2.0 mg/kg. Hương cực mạnh chanh tươi đậm đặc, citral-class-leader. Lemon myrtle thương mại hóa từ 1997 — modern Australian niche emergence rail. Tiếp tục Mini-Batch 26b heterogeneity-progression (myrtle-bog Myricaceae-clean → myrtle-lemon Myrtaceae-citral-HARD-CAP [oil này] → nagarmotha Cyperaceae-clean).
Năng Lượng & Ngũ Hành
§11 Energetics — TCM, Ayurveda, aromatic energetics
  • Five Element: Fire (intense citral-DOMINANT activating class; passion + transformation); Wood (lemon-fresh-class)
  • Chakra: Solar plexus (3rd) — citral-activating-class; Throat (5th) — clarifying citral-class
  • Ayurvedic: Pitta-clearing via cooling-citrus-class (PARADOX: citral is also Pitta-aggravating in excess — moderation rail); Kapha-clearing via stimulating citral-class; Vata-balancing only at very low dilution
  • TCM: Fire element + heart-supporting via clarifying citral-class
  • Mood: Uplifting + clarifying + activating per citral-class profile
  • Heritage: Australian Queensland-rainforest endemic + Aboriginal traditional heritage centuries traditional bush-tucker + medicinal PLANT use; CRITICAL: PLANT use NOT concentrated EO — modern EO from commercial cultivation only since 1997 emergence; cultural-respect rail mandatory (Aboriginal Queensland indigenous heritage); modern niche aromatherapy + food-flavoring industry; B216 EXPLICIT "Lemon myrtle oil became commercially available in 1997"

Dữ Liệu Kỹ Thuật Y Khoa

§14 Renderer Contract — Tisserand & Young V2.2

Thông Số Định Lượng

hazards
["drug_interaction_TY_EXPLICIT_VERBATIM_p713","teratogenicity_TY_EXPLICIT_VERBATIM_p713","skin_sensitization_TY_EXPLICIT_VERBATIM_p713","cyp2b6_inhibition_table_4_11B_bupropion_efavirenz_cyclophosphamide_ifosfamide_ketamine_methadone_nevirapine_TY_EXPLICIT","antidiabetic_medication_table_4_10B_TY_EXPLICIT","citral_teratogenicity_via_retinoic_acid_synthesis_inhibition_TY_EXPLICIT","citral_skin_sensitization_above_0_5_pct_patch_test_TY_EXPLICIT","ifra_2009_citral_0_6_pct_body_oils_lotions_cap_TY_EXPLICIT","max_dermal_0_7_pct_TY_EXPLICIT_VERBATIM_HARD_CAP","max_oral_pregnancy_46_mg_day_TY_EXPLICIT_VERBATIM","geranial_46_to_60_pct_MAJOR_DOMINANT","neral_32_to_40_pct_secondary","total_citral_78_to_100_pct_HIGHEST_IN_COMMERCIAL_TRADE","hypersensitive_diseased_damaged_skin_avoid_TY_EXPLICIT","children_under_2_avoid_dermal_TY_EXPLICIT","diabetes_medication_pregnancy_oral_caution_TY_EXPLICIT","hayes_markovic_2002_cytotoxic_hepg2_f1_73_fibroblast_noael_0_5_mg_L","hayes_markovic_2003_skin_penetration_kinetics_accidental_spill_10ml_exceeds_noael","burke_2004_children_4_6yr_10_pct_olive_oil_21_days_no_adverse_clinical","veien_2004_217_dermatitis_patients_2_pct_no_reaction_clinical","modak_mukhopadhaya_2011_citral_antidiabetic_rat_model","may_be_adulterated_synthetic_citral_quality_TY_EXPLICIT","australian_queensland_rainforest_endemic_TY_EXPLICIT","commercial_availability_since_1997_TY_EXPLICIT"]
phototoxic
false
safety_level
caution
cap_derivation
TY_EXPLICIT_HARD_CAP_0_7_PCT_ADULT_DERMAL_VIA_CITRAL_90_PCT_TIMES_CHAPTER_14_CITRAL_0_6_PCT_DERMAL_LIMIT_PLUS_46_MG_DAY_ORAL_PREGNANCY_VIA_CITRAL_90_PCT_TIMES_0_6_MG_KG_TIMES_70_KG_PLUS_GERANIAL_46_TO_60_PCT_MAJOR_DOMINANT_PLUS_NERAL_32_TO_40_PCT_SECONDARY_PLUS_TOTAL_CITRAL_78_TO_100_PCT_HIGHEST_IN_COMMERCIAL_TRADE_PLUS_TY_HAZARDS_DRUG_INTERACTION_AND_TERATOGENICITY_AND_SKIN_SENSITIZATION_PLUS_TY_CYP2B6_INHIBITION_TABLE_4_11B_BUPROPION_EFAVIRENZ_CYCLOPHOSPHAMIDE_IFOSFAMIDE_KETAMINE_METHADONE_NEVIRAPINE_PLUS_TY_TERATOGENICITY_VIA_CITRAL_RETINOIC_ACID_SYNTHESIS_INHIBITION_PLUS_TY_SKIN_SENSITIZATION_PATCH_TEST_ABOVE_0_5_PCT_PLUS_IFRA_2009_CITRAL_0_6_PCT_BODY_OILS_LOTIONS_PLUS_HAYES_MARKOVIC_2002_CYTOTOXIC_HEPG2_F1_73_FIBROBLAST_NOAEL_0_5_MG_L_PLUS_BURKE_2004_CHILDREN_4_6YR_10_PCT_OLIVE_OIL_21_DAYS_NO_ADVERSE_PLUS_VEIEN_2004_217_PATIENTS_2_PCT_NO_REACTION_PLUS_HAYES_MARKOVIC_2003_ACCIDENTAL_SPILL_10ML_EXCEEDS_NOAEL_PLUS_PREGNANCY_AVOID_DERMAL_PLUS_CHILDREN_UNDER_2_AVOID_DERMAL_PLUS_HYPERSENSITIVE_DAMAGED_SKIN_AVOID_PLUS_QUALITY_MAY_BE_ADULTERATED_SYNTHETIC_CITRAL_PLUS_AUSTRALIAN_QUEENSLAND_RAINFOREST_ENDEMIC_PLUS_COMMERCIAL_AVAILABILITY_SINCE_1997
oxidation_risk
high
max_dilution_2_6
0.35
drug_interactions
["cyp2b6_inhibitors_table_4_11B_bupropion_efavirenz_cyclophosphamide_ifosfamide_ketamine_methadone_nevirapine","antidiabetic_medication_table_4_10B_warfarin_sulfonylureas_insulin_metformin"]
max_dilution_6_12
0.5
shelf_life_months
24
max_dilution_adult
0.7
contraindicated_all
false
max_dilution_elderly
0.35
max_oral_dose_mg_day
200
max_dilution_sensitive
0.35
max_dilution_adult_face
0.35
contraindicated_children
true
contraindicated_pregnancy
true
max_dilution_child_under2
0
max_dilution_breastfeeding
0.35
max_dilution_pregnancy_1st
0
max_dilution_pregnancy_2nd
0
max_dilution_pregnancy_3rd
0
max_oral_dose_mg_day_pregnancy
46

Luận Giải Văn Cảnh

hazards

hazards: [drug_interaction_TY_EXPLICIT_VERBATIM_p713, teratogenicity_TY_EXPLICIT_VERBATIM_p713, skin_sensitization_TY_EXPLICIT_VERBATIM_p713, cyp2b6_inhibition_table_4_11B_bupropion_efavirenz_cyclophosphamide_ifosfamide_ketamine_methadone_nevirapine_TY_EXPLICIT, antidiabetic_medication_table_4_10B_TY_EXPLICIT, citral_teratogenicity_via_retinoic_acid_synthesis_inhibition_TY_EXPLICIT, citral_skin_sensitization_above_0_5_pct_patch_test_TY_EXPLICIT, ifra_2009_citral_0_6_pct_body_oils_lotions_cap_TY_EXPLICIT, max_dermal_0_7_pct_TY_EXPLICIT_VERBATIM_HARD_CAP, max_oral_pregnancy_46_mg_day_TY_EXPLICIT_VERBATIM, geranial_46_to_60_pct_MAJOR_DOMINANT, neral_32_to_40_pct_secondary, total_citral_78_to_100_pct_HIGHEST_IN_COMMERCIAL_TRADE, hypersensitive_diseased_damaged_skin_avoid_TY_EXPLICIT, children_under_2_avoid_dermal_TY_EXPLICIT, diabetes_medication_pregnancy_oral_caution_TY_EXPLICIT, hayes_markovic_2002_cytotoxic_hepg2_f1_73_fibroblast_noael_0_5_mg_L, hayes_markovic_2003_skin_penetration_kinetics_accidental_spill_10ml_exceeds_noael, burke_2004_children_4_6yr_10_pct_olive_oil_21_days_no_adverse_clinical, veien_2004_217_dermatitis_patients_2_pct_no_reaction_clinical, modak_mukhopadhaya_2011_citral_antidiabetic_rat_model, may_be_adulterated_synthetic_citral_quality_TY_EXPLICIT, australian_queensland_rainforest_endemic_TY_EXPLICIT, commercial_availability_since_1997_TY_EXPLICIT]

storage

oxidation_risk: high

dilution

max_dilution_adult: 0

botanical

latin_name: Backhousia citriodora F

chemistry

dominant_constituent: Geranial

commercial

availability: limited

oil_metadata

slug: myrtle-lemon

safety_flags

phototoxic: FALSE

Tài Liệu Y Khoa Tham Khảo

  • B216 (Tisserand & Young 2014, "Essential Oil Safety, 2nd Ed.") — Ch.13 p.713 Myrtle (lemon) profile (primary source)
  • Southwell et al 2000Backhousia citriodora essential oil chemistry profile (cited in B216 Ch.13 p.713)
  • Veien et al 2004 — Danish dermatitis study 0/217 reactive at 2% lemon myrtle oil
  • Burke et al 2004 — 31 children mean age 4.6yr 10% lemon myrtle in olive oil 21 days clinical molluscum contagiosum trial
  • Hayes & Markovic 2002 — Cytotoxicity HepG2 + F1-73 + skin fibroblasts NOAEL 0.5 mg/L
  • Hayes & Markovic 2003 — Skin penetration kinetics 100µL undiluted 12hr neral + geranial only detected, 0.02 mg/kg adult / 0.14 mg/kg child below NOAEL
  • Modak & Mukhopadhaya 2011 — Citral 10/15/20 mg/kg/day 28 days antidiabetic effect rat model
  • B216 Citral profile Chapter 14 — CYP2B6 inhibition + teratogenicity + skin-sensitization 0.5% + anticarcinogenic-class
  • B216 Geranial + Neral profiles Chapter 14 — citral isomer profiles
  • IFRA 2009 — citral 0.6% body oils + lotions skin-sensitization cap
  • B216 Table 4.10B — antidiabetic medication drug-interaction reference
  • B216 Table 4.11B — CYP2B6 drug-interaction reference